This is a rare bacterial infection that affects the nose and throat. It causes sores and growths in the nose. It's caused by a specific type of bacteria called Klebsiella rhinoscleromatis. It's not very common, but it can cause problems if not treated.
Every report comes from a Lived member, sent anonymously.
Have you tried Cipro (Ciprofloxacin) for Rhinoscleroma?
Rhinoscleroma, also called scleroma, is a rare, long-lasting bacterial infection of the airway that usually begins inside the nose. The bacterium, Klebsiella rhinoscleromatis, provokes a slow inflammatory reaction that builds up firm, lumpy tissue and, over time, scar tissue. That tissue can crust, bleed, block the nasal passages and eventually change the shape of the nose. The nose is affected in nearly all cases, but the disease can spread to the sinuses, the back of the throat, the voice box and the windpipe. It develops over months to years. Early on it looks like an ordinary stubborn nasal infection, later it forms nodules or a mass, and in untreated disease it scars and narrows the passages it involves. Because it is so uncommon in the United States, it is often mistaken for other nasal problems at first, which can delay the right treatment.
The infection is caused by Klebsiella rhinoscleromatis, a relative of more familiar Klebsiella bacteria. Exposure alone does not seem to be enough: some people living closely with an affected person develop it, which suggests spread through prolonged household contact, but many exposed people never do. Researchers suspect that a person's immune response, and possibly inherited factors, help decide who becomes ill. Rhinoscleroma is still found in parts of North and Central Africa, the Middle East, Central and South America, Eastern Europe and parts of Asia. It is most often reported in crowded, low-income rural settings, where poor nutrition and limited access to care may play a part. Most cases occur in young and middle-aged adults. In the United States it is usually seen in people who have lived in or traveled to one of these regions.
A specialist in ear, nose and throat conditions (an otolaryngologist) usually looks inside the nose and throat with a thin camera called an endoscope. Rhinoscleroma is suspected when crusting, blockage or a nasal growth keeps coming back despite standard treatment, especially in someone from a region where the infection occurs. The diagnosis is confirmed with a biopsy, a small tissue sample examined under a microscope. Pathologists look for large foamy immune cells, called Mikulicz cells, that contain the bacteria; this pattern separates rhinoscleroma from look-alikes such as tuberculosis, other granulomatous diseases and cancer. A culture of the tissue or nasal discharge can grow the bacterium, but cultures are positive in only about 50 to 60 percent of cases, so a negative culture does not rule the disease out. CT or MRI scans show how far the disease has spread into the sinuses and surrounding structures. If there are voice or breathing symptoms, the voice box and windpipe are examined too, because disease outside the nose is easy to miss and can be a reason it returns.
Antibiotics are the foundation of treatment and are needed in every case, because surgery alone leaves the infection behind. The bacteria live inside immune cells, where many drugs reach them poorly, so treatment is long: commonly from about six weeks to six months, and sometimes longer. There is no single agreed regimen. Ciprofloxacin, a fluoroquinolone antibiotic, is now the most commonly used option, often combined with another antibiotic such as doxycycline (a tetracycline) or trimethoprim-sulfamethoxazole. The choice is guided by culture results when they are available. Surgery helps when scarring or bulky tissue blocks breathing or has deformed the nose. It can remove obstructing tissue, open narrowed passages and repair the nose. Specialists generally recommend bringing the infection under control with antibiotics first, then operating, and continuing antibiotics afterward. When the windpipe is narrowed, endoscopic procedures can widen it, and a surgical airway may occasionally be needed. All of this evidence comes from case reports and small case series. No clinical trials compare one regimen with another.
Rhinoscleroma progresses slowly, and the earlier it is treated, the less permanent damage it tends to leave. Antibiotics can stop the active infection, but scarring that has already formed, such as narrowing of the nostrils, changes in the shape of the nose or loss of smell, may remain and may need surgery to improve. The course of treatment is long, and finishing it matters, because stopping early is linked with the disease coming back. Recurrence is common even after successful treatment, so close follow-up with the specialist continues after antibiotics end, with a repeat biopsy if new crusting or tissue appears. Rarely, long-standing disease has been followed by a type of skin-cell cancer (squamous cell carcinoma), which is another reason ongoing checks are worthwhile.
See a doctor, ideally an ear, nose and throat specialist, if nasal crusting, blockage, bleeding or a growth inside the nose persists for weeks despite usual treatment, particularly if you have lived in or traveled to a region where rhinoscleroma occurs. If you have rhinoscleroma, contact your care team promptly about new hoarseness, a persistent cough or breathlessness during activity, since these can mean the voice box or windpipe is involved. Also report any return of crusting, blockage or nasal swelling after treatment. Noisy, high-pitched breathing (stridor) or struggling to breathe can mean the airway is dangerously narrowed. Call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Rhinoscleroma is like, what's helped you, or ask the community a question.